Nature

23 articles in the TruthFoundry index. Each links out to the original.

• Academic citations review cardiovascular impacts of protein misfolding diseases · Compiled published research citations examine cardiac and vascular protein misfolding conditions
• New cardiac mechanism identified for SGLT2 inhibitor heart failure benefits · Research identifies PANK1 as direct cardiac target for SGLT2 inhibitor cardioprotection.
• Bibliography Documents Evolution Of Conduction System Pacing Research · This content is a curated collection of academic citations for cardiac conduction system pacing.
• Cardiology researchers reply to nicotine therapy correspondence · Münzel et al respond to critique distinguishing NRT from consumer nicotine products
• POET II trial finds shorter endocarditis antibiotics carry higher relapse risk · POET II trial evaluates tailored shorter antibiotic therapy for infective endocarditis.
• Correspondence distinguishes NRTs from consumer nicotine products · Nature Reviews Cardiology note differing cardiovascular safety for NRTs vs consumer nicotine products.
• Academic Review Compiles Research On Centenarian Cardiovascular Resilience · This document aggregates published studies on cardiovascular health in human centenarian populations.
• Bibliography of research on global venous thromboembolism burden · Provided content is a reference list of medical papers on venous thromboembolism.
• Review covers stem cell methods for lab generated human heart cells · Cardiac research review evaluates stem cell models for producing human cardiomyocytes.
• High altitude hypoxia linked to congenital heart defects via adenosine receptor · Research review outlines hypoxia mechanisms causing embryonic cardiac malformations
• TRIC-I-HF-DZHK24 trial finds tricuspid repair reduces death and HF hospitalization · TRIC-I-HF-DZHK24 trial shows tricuspid repair improves outcomes over standalone medical therapy
• Cardioimmunology Advances: T Cell Responses and Disease Mechanisms · Recent research elucidates specific T cell responses and inflammatory mechanisms driving cardiovascular diseases.
• Aficamten Improves Exercise Capacity in Non-Obstructive Hypertrophic Cardiomyopathy · Aficamten significantly improved exercise capacity and health status in patients with non-obstructive hypertrophic cardiomyopathy.
• Genetic Cardiomyopathy-Associated Myocarditis: Competing Interests Disclosed · Researchers disclose funding and personal fees from pharmaceutical companies regarding genetic cardiomyopathy-associated myocarditis.
• Pulmonary artery denervation trial shows positive heart failure results · PADN-HF-PH trial finds denervation reduces clinical worsening risk for heart failure patients.
• 1970s omega-3 research established global oily fish dietary guidelines · 1970s Inuit diet research linked omega-3 fatty acids to reduced cardiovascular risk.
• Researchers present Langendorff-free method for adult mouse heart dissociation · Ackers-Johnson and Pavlovic present a Langendorff-free method for isolating adult mouse cardiomyocytes, avoiding aortic cannulation.
• Review Authors Prioritize Adipose Phenotype Over Echocardiography for Cardiac Risk · Authors argue adipose tissue phenotype is superior to quantity for cardiometabolic risk assessment.
• Bedside echocardiographic epicardial fat assessment remains relevant in advanced phenotyping era · Correspondence argues bedside echocardiographic EAT assessment remains vital despite advanced adipose phenotyping, citing a 125-patient study.
• Eric Feigl's 1983 Framework for Coronary Metabolic Mediators · A review details Eric Feigl's 1983 criteria for identifying coronary metabolic dilators.
• Hypoxia-Inducible Factors in Myocardial Ischemia and Cardioprotection · Research reviews the role of hypoxia-inducible factors in myocardial ischemia-reperfusion injury and potential cardioprotective mechanisms.
• Randomized Trials Compare Intracoronary Imaging to Angiography in PCI · Large randomized trials evaluate intravascular ultrasound and optical coherence tomography versus angiography for percutaneous coronary intervention.
• Dyslipidaemia and hepatic steatosis: mechanisms and implications for lipid-lowering therapy · Review details metabolic mechanisms linking liver fat accumulation to cardiovascular disease and therapeutic strategies.